Clinical-Pathological Features and Overexpression of Her-2 Receptors in Patients with Prostate Cancer at Bugando Medical Center, Mwanza, Tanzania. (Record no. 29096)

MARC details
000 -LEADER
fixed length control field 02854nam a22003257a 4500
001 - CONTROL NUMBER
control field 20241009130647.0
003 - CONTROL NUMBER IDENTIFIER
control field 20241009130647.0
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20241009131055.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 241009b |||||||| |||| 00| 0 eng d
028 ## - PUBLISHER OR DISTRIBUTOR NUMBER
Source Wurzburg Road 35, Premises, Post Code: 33102 |
Source P. O. Box 1464 Mwanza, Tanzania |
Source Phone: (255) 28-298-3384 |
Source Fax: (255) 28-298-3386 |
Source Email: vc@bugando.ac.tz |
Source Website: www.bugando.ac.tz
040 ## - CATALOGING SOURCE
Transcribing agency ddc
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title English
Language code of text/sound track or separate title Kiswahili
100 ## - MAIN ENTRY--PERSONAL NAME
Relator term CUHAS/MMED/6000467/T/21
Fuller form of name Maria Beda
245 ## - TITLE STATEMENT
Title Clinical-Pathological Features and Overexpression of Her-2 Receptors in Patients with Prostate Cancer at Bugando Medical Center, Mwanza, Tanzania.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Mwanza, Tanzania |
Name of publisher, distributor, etc. Catholic University of Health and Allied Sciences [CUHAS-Bugando] |
Date of publication, distribution, etc. 2024.
300 ## - PHYSICAL DESCRIPTION
Extent 91 Pages
Extent Includes References
520 ## - SUMMARY, ETC.
Summary, etc. <br/>Abstract:<br/><br/>Background: Overexpression of the human epidermal growth factor receptor 2 (HER-2) has been associated with aggressive progression and high mortality in patients with prostate cancer. HER-2-targeted therapy has been suggested to be of therapeutic importance in prostate cancer patients who do not respond to a commonly used treatment modality. Therefore, this study aims to determine HER-2 overexpression in prostate cancer and its association with clinical-pathological.<br/><br/>Methodology: This was a laboratory-based, cross-sectional study involving 97 patients with prostate adenocarcinoma. Tissue blocks were retrieved for immunohistochemistry (IHC) staining of HER-2 on which tissue microarray was don. Monoclonal antibodies to HER-2(ref no: A0485, lot no: 4140026(DAKO) used. The IHC staining scores of +2 and +3 were considered positive.<br/><br/>Results: A total number of 97 cases were included in this study, the median PSA level was 102ng/ml (range, 60 – 400ng/ml). HER-2 membrane overexpression was observed in 50 of 97 (51.55%) the cases, while 47cases (48.45%) were negative. There was a significant association of HER-2 overexpression with PSA level (P value 0.006) and Gleason grade (P value 0.012).<br/><br/>Conclusion: Prostate cancer in our setting showed a high level of HER-2 overexpression. These findings recommend further studies including clinical trials to be done for all patients with a high Gleason score and elevated PSA for HER-2 overexpression so that they can benefit from targeted therapy (trastuzumab).<br/><br/>
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Pathology
700 ## - ADDED ENTRY--PERSONAL NAME
Fuller form of name Oscar Ottoman Muhini
Fuller form of name Peter Fabian Rambau
856 ## - ELECTRONIC LOCATION AND ACCESS
Public note A dissertation submitted in partial fulfillment of the requirements of the award of Master of Medicine in Anatomical Pathology of Catholic University of Health and Allied Sciences (CUHAS).
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type POSTGRADUATE DISSERTATIONS
Suppress in OPAC
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Date acquired Total checkouts Barcode Date last seen Price effective from Koha item type
          MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO 10/09/2024   20241009130647.0 10/09/2024 10/09/2024 POSTGRADUATE DISSERTATIONS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024